A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer
Clinical trial NCT02225093 · COMPLETED
Trial details
- NCT number
- NCT02225093
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-02
- Primary completion
- 2014-02-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.